Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells

Molecular Cancer Therapeutics

Volumn 3, Issue 8, 2004, Pages 955-967

  Rinne, Mikael ^a   Caldwell, David ^a   Kelly, Mark R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DIMETHYL SULFATE; DNA GLYCOSYLTRANSFERASE; MESYLIC ACID METHYL ESTER; METHOXYAMINE; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA; TEMOZOLOMIDE;

APURINIC SITE; APYRIMIDINIC SITE; BREAST CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVITY; EXCISION REPAIR; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW;

ADENOVIRIDAE; ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COMET ASSAY; DACARBAZINE; DNA GLYCOSYLASES; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE THERAPY; GENETIC VECTORS; HUMANS; HYDROXYLAMINES; IMMUNOHISTOCHEMISTRY; METHYL METHANESULFONATE; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA; OLIGONUCLEOTIDES; SENSITIVITY AND SPECIFICITY; SULFURIC ACID ESTERS; TIME FACTORS;

EID: 4444381880     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practices. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
2. Otterlei M, Kavli B, Standal R, Skjelbred C, Bharati S, Krokan HE. Repair of chromosomal abasic sites in vivo involves at least three different repair pathways. EMBO J 2000;19:5542-51.
3. Limp-Foster M, Kelley MR. DNA repair and gene therapy: implications for translational uses. Environ Mol Mutagen 2000;35:71-81.
4. Krokan HE, Standal R, Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem J 1997;325 Pt 1:1-16.
5. Lockhart ML, Deutsch JF, Yamaura I, Cavalieri LF, Rosenberg BH. Termination of DNA synthesis in vitro at apurinic sites but not at ethyl adducts on the template. Chem Biol Interact 1982;42:85-95.
6. Sagher D, Strauss B. Insertion of nucleotides opposite apurinic/ apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: uniqueness of adenine nucleotides. Biochemistry 1983;22:4518-26.
7. Zhou W, Doetsch PW. Effects of abasic sites and DNA single-strand breaks on prokaryotic RNA polymerases. Proc Natl Acad Sci USA 1993; 90:6601-5.
8. Michel B, Ehrlich SD, Uzest M. DNA double-strand breaks caused by replication arrest. EMBO J 1997;16:430-8.
9. Loeb LA. Apurinic sites as mutagenic intermediates. Cell 1985;40: 483-4.
10. Gentil A, Cabral-Neto JB, Mariage-Samson R, et al. Mutagenicity of a unique apurinic/apyrimidinic site in mammalian cells. J Mol Biol 1992;227: 981-4.
11. Klinedinst DK, Drinkwater NR. Mutagenesis by apurinic sites in normal and ataxia telangiectesia human lymphoblastoid cells. Mol Carcinog 1992; 6:32-42.
12. Amabile-Cuevas CF, Demple B. Molecular characterization of the soxRS genes of Escherichia coli: two genes control a superoxide stress regulon. Nucleic Acids Res 1991;19:4479-84.
13. Whitehouse CJ, Taylor RM, Thistlethwaite A, et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001;104:107-17.
14. Chaudhry A, Weinfeld M. Reactivity of human apurinic/apyrimidinic endonuclease and Escherichia coli exonuclease III with bistranded abasic sites in DNA. J Biol Chem 1997;272:15650-5.
15. Kampinga HH, Kanon B, Konings AW, Stackhouse MA, Bedford JS. Thermal radiosensitization in heat- and radiation-sensitive mutants of CHO cells. Int J Radiat Biol 1993;64:225-30.
16. Ibeanu G, Hartenstein B, Dunn WC, et al. Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis 1992;13:1989-95.
17. Bonanno K, Wyrzykowski J, Chong W, Matijasevic Z, Volkert MR. Alkylation resistance of E. coli cells expressing different isoforms of human alkyladenine DNA glycosylase (hAAG). DNA Repair (Amst) 2002;1:507-16.
18. Pendlebury A, Frayling IM, Koref MFS, Margison GP, Rafferty JA. Evidence for the simultaneous expression of alternatively spliced alkylpurine N-glycosylase transcripts in human tissues and cells. Carcinogen. Carcinogenesis 1994;15:2957-60.
19. Saparbaev M, Laval J. Excision of hypoxanthine from DNA containing dIMP residues by the Escherichia coli, yeast, rat, and human alkylpurine DNA glycosylases. Proc Natl Aced Sci USA 1994;91:5873-7.
20. 6-ethenoadenine is preferred over 3-methyladenine as substrate by a cloned human N-methyl-purine-DNA glycosylase (3-methyladenine-DNA glycosylase). Biochemistry 1994;33:1624-8.
21. Bessho T, Roy R, Yamamoto K, et al. Repair of 8-hydroxyguanine in DNA by mammalian N-methylpurine-DNA glycosylase. Proc Natl Acad Sci USA 1993;90:8901-4.
22. Coquerelle T, Dosch J, Kaina B. Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents - a case of imbalanced DNA repair. Mutat Res 1995;336:9-17.
23. Posnick LM, Samson LD. Imbalanced base excision repair increases spontaneous mutation and alkylation sensitivity in Escherichia coli. J Bacteriol 1999;181:6763-71.
24. Fishel ML, Seo YR, Smith ML, Kelley MR. Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing. Cancer Res 2003;63:608-15.
25. 6 -alkylguanine DNA-alkyltransferase or poly (ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide. Mol Pharmacol 1997;52:249-58.
26. Berdal KG, Johansen RF, Seeberg E. Release of normal bases from intact DNA by a native DNA repair enzyme. EMBO J 1998;17:363.
27. Dobson AW, Xu Y, Kelley MR, LeDoux SP, Wilson GL. Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria [in process citation]. J Biol Chem 2000;275:37518-23.
28. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 1996;226:561-5.
29. Hung MC, Hortobagyi GN, Ueno NT. Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer. Adv Exp Med Biol 2000;465:171-80.
30. Rosatelli MC, Altay C, Oner R, et al. β-globin haplotype and Xmnl polymorphism at position G γ-158 and HbF production in Fanconi's anemia. Haematologica 1992;77:106-9.
31. DC OS, Mynderse L, Barrett DM. Subcutaneous port for long-term access and administration of topical chemotherapy to the upper urinary tract. J Urol 1993;150:1034-7.
32. Kreklau EL, Limp-Foster M, Liu N, Xu Y, Kelley MR, Erickson LC. A novel fluorometric oligonucleotide assay to measure O(6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma calls overexpressing methylpurine DNA glycosylase. Nucleic Acids Res 2001;29:2558-66.
33. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82: 1107-12.
34. Pauwels B, Korst AE, de Pooter CM, et al. Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemo-radiation studies. Cancer Chemother Pharmacol 2003;51:221-6.
35. Rubinstein LV, Shoemaker RH, Paull KD, et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 1990;82:1113-8.
36. Lamb JR, Goehle S, Ludlow C, Simon JA. Thymidine incorporation is highly predictive of colony formation and can be used for high-throughput screening. Biotechniques 2001;30:1118-20, 1122, 1124.
37. Fairbairn DW, Olive PL, O'Neill KL. The comet assay: a comprehensive review. Mutat Res 1995;339:37-59.
38. Tice RR, Agurell E, Anderson D, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;35:206-21.
39. Kang SG, Lee E, Schaus S, Henderson E. Monitoring transfected cells without selection agents by using the dual-cassette expression EGFP vectors. Exp Mol Med 2001;33:174-8.
40. Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 1990;231: 11-30.
41. Nagasubramanian R, Dolan ME. Temozolomide: realizing the promise and potential. Curr Opin Oncol 2003;15:412-8.
42. Denny BJ, Wheelhouse RT, Stevens MF, Tsang LL, Slack JA. NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 1994;33:9045-51.
43. Fortini P, Calcagnile A, Vrieling H, van Zeeland AA, Bignami M, Dogliotti E. Mutagenic processing of ethylation damage in mammalian cells: the use of methoxyamine to study apurinic/apyrimidinic site-induced mutagenesis. Cancer Res 1993;53:1149-55.
44. Liuzzi M, Talpaert-Borle M. A new approach to the study of the base-excision repair pathway using methoxyamine. J Biol Chem 1985;260: 5252-8.
45. Horton JK, Prasad R, Hou E, Wilson SH. Protection against methylation-induced cytotoxicity by DNA polymerase β-dependent long patch base excision repair. J Biol Chem 2000;275:2211-8.
46. Liu L, Qin X, Gerson SL. Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cell. Carcinogenesis 1999; 20:279-84.
47. Taverna P, Liu L, Hwang HS, Hanson AJ, Kinsella TJ, Gerson SL. Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells. Mutat Res 2001; 485:269-81.
48. Atamna H, Cheung I, Ames BN. A method for detecting abasic sites in living cells: age-dependent changes in base excision repair. Proc Natl Acad Sci USA 2000;97:686-91.
49. Wilson SH, Kunkel TA. Passing the baton in base excision repair. Nat Struct Biol 2000;7:176-8.
50. Grever MR, Grieshaver CK. Principles of chemotherapy: toxicology by organ system. 5th ed. London: B.C. Decker; 2000.
51. Krokan HE, Nilsen H, Skorpen F, Otterlei M, Slupphaug G. Base excision repair of DNA in mammalian cells. FEBS Lett 2000;476:73-7.
52. Wyatt MD, Allan JM, Lau AY, Ellenberger TE, Samson LD. 3-Methyladenine DNA glycosylases: structure, function, and biological importance. BioEssays 1999;21:668-76.
53. Glassner BJ, Rasmussen LJ, Samson LD. Generation of a strong mutator phenotype in yeast by imbalanced base. Proc Natl Acad Sci 1998;95:9997.
54. Yung WK. Future directions for temozolomide therapy. Semin Oncol 2001;28 Suppl 13:43-6.
55. Wilstermann AM, Osheroff N. Base excision repair intermediates as topoisomerase II poisons. J Biol Chem 2001;8:8.
56. Sabourin M, Osheroff N. Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions. Nucleic Acids Res 2000;28:1947-54.
57. Kingma PS, Osheroff N. Apurinic sites are position-specific topoisomerase II poisons. J Biol Chem 1997;272:1148-55.
58. Kingma PS, Greider CA, Osheroff N. Spontaneous DNA lesions poison human topoisomerase IIα and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints. Biochemistry 1997;36: 5934-9.
59. Liu L, Yan L, Donze JR, Gerson SL. Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts. Mol Cancer Ther 2003;2:1061-6.
60. Liu L, Nakatsuru Y, Gerson SL. Base excision repair as a therapeutic target in colon cancer. Clin Cancer Res 2002;8:2985-91.
61. Liu L, Taverna P, Whitacre CM, Chatterjee S, Gerson SL. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents. Clin Cancer Res 1999;5:2908-17.
62. Glassner BJ, Rasmussen LJ, Najarian MT, Posnick LM, Samson LD. Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc Natl Acad Sci USA 1998;95:9997-10002.
63. Calleja F, Jansen JG, Vrieling H, Laval F, van Zeeland AA. Modulation of the toxic and mutagenic effects induced by methyl methanesulfonate in Chinese hamster ovary cells by overexpression of the rat N-alkylpurine-DNA glycosylase. Mutat Res 1999;425:185-94.
64. St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003;10:1135-41.
65. Vorburger SA, Hunt KK. Adenoviral gene therapy. Oncologist 2002;7: 46-59.